NEW YORK (GenomeWeb News) – BioGenex and Abbott Molecular today announced that BioGenex will take over direct sales and support responsibility for the co-branded Xmatrx instruments, auto FISH reagents, and consumables.

The two firms had a "long and successful collaboration and partnership," said BioGenex, centered on BioGenex's Xmatrx platform, and in 2009 extended an assay deal to market the Xmatrx platform for the automation of Abbott's FISH product line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.